Avantor (AVTR) Net Income towards Common Stockholders (2018 - 2026)
Avantor's (AVTR) quarterly Net Income towards Common Stockholders came in at $43.3 million in Q1 2026, down 32.87% year-on-year from $64.5 million in Q1 2025, and down 17.37% quarter-over-quarter from $52.4 million in Q4 2025.
Avantor (AVTR) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
Avantor's Net Income towards Common Stockholders history runs 9 years deep, the most recent figure standing at $43.3 million for Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 32.87% year-over-year to $43.3 million in Q1 2026; TTM through Mar 2026 was -$551.4 million, a 177.05% decrease from a year earlier, with the FY2025 full-year figure at -$530.2 million, down 174.52% from the prior year.
- Net Income towards Common Stockholders eased to $43.3 million in Q1 2026 per AVTR's latest filing, from $52.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $500.4 million in Q4 2024 and bottomed at -$711.8 million in Q3 2025.
- The 5-year median for Net Income towards Common Stockholders is $92.9 million (2024), against an average of $71.1 million.
- Across the five-year window, Net Income towards Common Stockholders surged 1372.6% in 2024 and plunged 1331.49% in 2025, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at $141.7 million in 2022, then sank by 30.49% to $98.5 million in 2023, then surged by 408.02% to $500.4 million in 2024, then plunged by 89.53% to $52.4 million in 2025, then retreated by 17.37% to $43.3 million in 2026.
- Per Business Quant, the three latest AVTR Net Income towards Common Stockholders figures stand at $43.3 million (Q1 2026), $52.4 million (Q4 2025), and -$711.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.84 Bn | 121.63 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.96 Bn | 44.15 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.82 Bn | 30.58 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.41 Bn | 22.97 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.09 Bn | 13.53 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Avantor | 7.96 Bn | 7.68 Bn | 500.70 Mn | 43.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.30 Mn |
| Dec 31, 2025 | 52.40 Mn |
| Sep 30, 2025 | -711.80 Mn |
| Jun 30, 2025 | 64.70 Mn |
| Mar 31, 2025 | 64.50 Mn |
| Dec 31, 2024 | 500.40 Mn |
| Sep 30, 2024 | 57.80 Mn |
| Jun 30, 2024 | 92.90 Mn |
| Mar 31, 2024 | 60.40 Mn |
| Dec 31, 2023 | 98.50 Mn |
| Sep 30, 2023 | 108.40 Mn |
| Jun 30, 2023 | -7.30 Mn |
| Mar 31, 2023 | 121.50 Mn |
| Dec 31, 2022 | 141.70 Mn |
| Sep 30, 2022 | 167.00 Mn |
| Jun 30, 2022 | 179.30 Mn |
| Mar 31, 2022 | 174.30 Mn |
| Dec 31, 2021 | 77.80 Mn |
| Sep 30, 2021 | 140.70 Mn |
| Jun 30, 2021 | 141.60 Mn |